NEW YORK – Biological Dynamics has developed and refined its electric field detection platform over the last year to capture, quantify, and analyze a variety of targets including extracellular DNA, RNA, proteins, and circulating vesicles directly from unprocessed samples.
The firm is now hoping that this work will pay off in new research partnerships fostered under the umbrella of a Microsoft commercial partnership program, to which it was accepted this January, said CEO Raj Krishnan.